This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

Intuitive Surgical capped off the recovery in its shares with a strong Q4 2025 earnings release, lending support to the stock ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Q4 2025 Management View CEO David Rosa described 2025 as “a strong year for Intuitive, driven by multi-specialty da Vinci ...

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the best US stocks to buy and hold in 2025. On July 2, Intuitive Surgical announced that its latest da Vinci 5 Surgical System received CE mark approval ...

SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...

Intuitive Surgical shares are trading flat Friday after the company reported Q4 financial results on Thursday after the market closed.